Charles River Laboratories International Inc (NYSE:CRL)
$ 234.9341 2.1141 (0.91%) Market Cap: 12.10 Bil Enterprise Value: 14.72 Bil PE Ratio: 27.57 PB Ratio: 3.32 GF Score: 95/100

Charles River Laboratories International Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 01, 2021 / 02:00PM GMT
Release Date Price: $332.9 (-1.51%)
David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

Hi. Good morning, everybody. Thank you again for joining our Jefferies Virtual Healthcare Conference. I'm Dave Windley, Jefferies' health care equity research. I cover pharma services space, including contract research and contract development and manufacturing organizations. And in that space, Charles River Labs has been a very effective and positive grower in the space and developer of very broad, as Jim will tell you, very broad portfolio of products and services to that pharma biotech R&D space.

So CEO, Jim Foster, I should say, excuse me, Chairman, President and CEO, Jim Foster, is here to talk with me about Charles River Labs. I'm going to turn it over to him to lay some groundwork, and then we'll have Q&A.

Jim, thanks.

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Thanks, Dave. Always a pleasure to talk to you. We had a really strong first quarter with sales grew 13%. Our operating margin was 20.7%

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot